Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/117201) titled 'A Clinical Study to Evaluate the Safety and Effectiveness of a Liver Care Formulation in Participants with Fatty Liver Disease' on Sept. 8.
Study Type: Interventional
Study Design:
Single Arm Study Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Not Applicable
Primary Sponsor: Veloce Herbals Private Limited
Condition:
Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified
Recruitment Status: Not Recruiting
Phase: Phase 3
Date of First Enrollment: 19-09-2026
Target Sample Size: 60
Countries of...